Cite
HARVARD Citation
Mevorach, D. et al. (n.d.). Therapy with eculizumab for patients with primary p.Cys89Tyr mutation in the CD59 gene avoids recurrent arterial thrombosis. Molecular immunology. pp. 186-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mevorach, D. et al. (n.d.). Therapy with eculizumab for patients with primary p.Cys89Tyr mutation in the CD59 gene avoids recurrent arterial thrombosis. Molecular immunology. pp. 186-. [Online].